Literature DB >> 8261567

Surveillance for the Expanded Programme on Immunization.

F T Cutts1, R J Waldman, H M Zoffman.   

Abstract

Surveillance is the foundation of public health practice. This review examines the experience of surveillance in the Expanded Programme on Immunization (EPI). Surveillance systems include routine reporting, sentinel surveillance, and community-based reporting. Data from ongoing surveillance should be linked with those from supervision, health facility assessments, population surveys, and outbreak investigations to provide information for programme planning, implementation, evaluation, and modification. Evaluation of surveillance systems should assess the extent to which data are used for policy-making and programme improvement, and the simplicity, accuracy, completeness, timeliness and cost of the data. The surveillance of vaccine-preventable diseases has evolved as programmes mature, to monitor progress towards disease control targets. The establishment of goals to reduce measles cases by 90%, eliminate neonatal tetanus, and eradicate poliomyelitis has put increased emphasis on the need for effective disease surveillance. This opportunity should be taken to promote strengthening of national routine systems for disease surveillance, to make them effective instruments for prevention and control of diseases of public health importance.

Entities:  

Keywords:  Behavior; Cdc; Data Collection; Data Reporting; Data Storage And Retrieval; Decision Making; Delivery Of Health Care; Developed Countries; Developing Countries; Diseases; Epidemiologic Methods; Government Agencies; Health; Health Services; Immunization; Infections; Information; Information Processing; Information Retrieval Systems--cost; International Agencies; Measles--prevention and control; Organizations; Poliomyelitis--prevention and control; Primary Health Care; Program Evaluation; Programs; Tetanus--prevention and control; Un; Usphs; Viral Diseases; Who

Mesh:

Year:  1993        PMID: 8261567      PMCID: PMC2393485     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  35 in total

1.  [Endemic emergence of yellow fever in the Ivory Coast: the place of anti-yellow fever IgM detection in the strategy of surveillance].

Authors:  M Lhuillier; J L Sarthou; R Cordellier; N Monteny; G M Gershy-Damet; B Bouchite
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

2.  Effectiveness of the Expanded Programme on Immunization.

Authors:  K Keja; C Chan; E Brenner; R Henderson
Journal:  World Health Stat Q       Date:  1986

3.  Assessing the impact of the expanded programme on immunization: the example of Indonesia.

Authors:  R Kim-Farley; T I Soewarso; A Karyadi; M Adhyatma
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

4.  Measles control in Yaounde: justification of a one dose, nine month minimum age vaccination policy in tropical Africa.

Authors:  D L Heymann; G K Mayben; K R Murphy; B Guyer; S O Foster
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

5.  Surveys to measure programme coverage and impact: a review of the methodology used by the expanded programme on immunization.

Authors:  S Lemeshow; D Robinson
Journal:  World Health Stat Q       Date:  1985

6.  Control of measles in Czechoslovakia (CSSR).

Authors:  J Sejda
Journal:  Rev Infect Dis       Date:  1983 May-Jun

7.  Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method.

Authors:  R H Henderson; T Sundaresan
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

Review 8.  Neonatal tetanus in the world today.

Authors:  J P Stanfield; A Galazka
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

9.  Comparison of techniques for the estimation of the prevalence of poliomyelitis in developing countries.

Authors:  B Joseph; R Ravikumar; M John; K Natarajan; M C Steinhoff; T J John
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

10.  Measles case fatality among the under-fives: a multivariate analysis of risk factors in a rural area of Bangladesh.

Authors:  A Bhuiya; B Wojtyniak; S D'Souza; L Nahar; K Shaikh
Journal:  Soc Sci Med       Date:  1987       Impact factor: 4.634

View more
  6 in total

1.  Surveillance of measles in England and Wales: implications of a national saliva testing programme.

Authors:  M Ramsay; R Brugha; D Brown
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

2.  Will Participatory Syndromic Surveillance Work in Latin America? Piloting a Mobile Approach to Crowdsource Influenza-Like Illness Data in Guatemala.

Authors:  José Tomás Prieto; Jorge H Jara; Juan Pablo Alvis; Luis R Furlan; Christian Travis Murray; Judith Garcia; Pierre-Jean Benghozi; Susan Cornelia Kaydos-Daniels
Journal:  JMIR Public Health Surveill       Date:  2017-11-14

3.  On the path to rabies elimination: The need for risk assessments to improve administration of post-exposure prophylaxis.

Authors:  K Rysava; M E Miranda; R Zapatos; S Lapiz; P Rances; L M Miranda; M C Roces; J Friar; S E Townsend; K Hampson
Journal:  Vaccine       Date:  2018-12-17       Impact factor: 3.641

4.  Surveillance guidelines for disease elimination: a case study of canine rabies.

Authors:  Sunny E Townsend; Tiziana Lembo; Sarah Cleaveland; François X Meslin; Mary Elizabeth Miranda; Anak Agung Gde Putra; Daniel T Haydon; Katie Hampson
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2012-12-20       Impact factor: 2.268

5.  Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization.

Authors:  Mark Jit; Thi Thanh Huyen Dang; Ingrid Friberg; Van Minh Hoang; Tuan Kiet Pham Huy; Neff Walker; Van Cuong Nguyen; Nhu Duong Tran; Kohei Toda; Raymond Hutubessy; Kimberley Fox; Tran Hien Nguyen
Journal:  Vaccine       Date:  2015-05-07       Impact factor: 3.641

6.  Validity of parental recalls to estimate vaccination coverage: evidence from Tanzania.

Authors:  Peter Binyaruka; Josephine Borghi
Journal:  BMC Health Serv Res       Date:  2018-06-13       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.